Your browser is no longer supported. Please, upgrade your browser.
Settings
TROV [NASD]
TrovaGene, Inc.
Index- P/E- EPS (ttm)-0.76 Insider Own11.67% Shs Outstand24.13M Perf Week-0.57%
Market Cap168.91M Forward P/E- EPS next Y-0.86 Insider Trans33.57% Shs Float20.05M Perf Month26.35%
Income-14.30M PEG- EPS next Q-0.22 Inst Own15.70% Short Float2.57% Perf Quarter60.18%
Sales0.30M P/S563.03 EPS this Y-8.60% Inst Trans10.28% Short Ratio1.96 Perf Half Y62.79%
Book/sh0.44 P/B15.91 EPS next Y3.40% ROA-47.10% Target Price8.33 Perf Year24.11%
Cash/sh1.13 P/C6.19 EPS next 5Y- ROE-103.20% 52W Range2.97 - 8.04 Perf YTD62.79%
Dividend- P/FCF- EPS past 5Y-9.20% ROI-63.90% 52W High-12.94% Beta-0.73
Dividend %- Quick Ratio6.20 Sales past 5Y-15.60% Gross Margin100.00% 52W Low135.69% ATR0.49
Employees31 Current Ratio6.20 Sales Q/Q19.10% Oper. Margin- RSI (14)58.87 Volatility8.79% 7.42%
OptionableYes Debt/Eq1.81 EPS Q/Q-400.00% Profit Margin- Rel Volume0.89 Prev Close6.77
ShortableYes LT Debt/Eq1.58 EarningsMar 12 AMC Payout- Avg Volume263.55K Price7.00
Recom2.00 SMA207.16% SMA5018.26% SMA20048.17% Volume233,583 Change3.40%
Jul-10-14Initiated Maxim Group Buy $10
Nov-13-13Reiterated Aegis Capital Buy $14 → $10
Oct-01-13Reiterated Aegis Capital Buy $14
Jul-16-13Initiated Cantor Fitzgerald Buy $10
Apr-01-13Reiterated Aegis Capital Buy $12 → $14
Dec-12-12Initiated Aegis Capital Buy $12
Mar-19-15 01:04PM  TROVAGENE, INC. Financials
Mar-18-15 11:59AM  TROVAGENE, INC. Files SEC form 8-K, Other Events
09:03AM  Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer at noodls
08:31AM  Matthew Posard Joins Trovagene's Executive Management Team as Chief Commercial Officer PR Newswire
08:20AM  TrovaGene (TROV) Enters Overbought Territory - Tale of the Tape
Mar-17-15 08:37AM  TrovaGene (TROV) in Focus: Stock Adds 6.1% in Session - Tale of the Tape +8.30%
Mar-13-15 09:40AM  TrovaGene (TROV) Posts Wider Q4 Loss on Higher Expenses - Analyst Blog
Mar-12-15 07:04PM  Trovagene, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results at noodls
05:36PM  Trovagene reports 4Q loss
04:19PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition
04:05PM  Trovagene, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results PR Newswire
Mar-10-15 04:52PM  What's in Store for TrovaGene (TROV) for Earnings Season? - Analyst Blog
Mar-03-15 12:16PM  TrovaGene Inc (TROV) Sees Bridger Management Buy More Shares; Other Stocks Roberto Mignone Loves at Insider Monkey +5.12%
Feb-26-15 05:51PM  Trovagene Schedules Release of Fourth Quarter and Year End 2014 Financial Results and Investor Conference Call at noodls +6.74%
04:05PM  Trovagene Schedules Release of Fourth Quarter and Year End 2014 Financial Results and Investor Conference Call PR Newswire
Feb-11-15 11:40AM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
11:11AM  Trovagene, Inc. Announces Closing of Public Offering of Common Stock at noodls
10:12AM  Trovagene, Inc. Announces Closing of Public Offering of Common Stock PR Newswire
Feb-10-15 08:05AM  Trovagene, Inc. to Present at Leerink Global Healthcare Conference PR Newswire +5.93%
Feb-09-15 12:46PM  TROVAGENE, INC. Files SEC form 8-K, Other Events
08:05AM  Clinical Results Demonstrate High Sensitivity of Trovagene's Urine-Based HPV Assay for the Detection of High Risk HPV and Pre-Cancerous Cervical Lesions PR Newswire
Feb-06-15 02:46PM  TROVAGENE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online -23.59%
12:57PM  TrovaGene Falls Sharply; Prices Offering Below Expectations Benzinga
08:27AM  Trovagene, Inc. Announces Pricing of Public Offering of Common Stock PR Newswire
Feb-05-15 04:17PM  TROVAGENE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
04:09PM  Trovagene, Inc. Announces Public Offering of Common Stock PR Newswire
Jan-29-15 01:06PM  3 Biotech Stocks Under $10 in Breakout Territory: TrovaGene and More at TheStreet
Jan-26-15 12:00PM  TrovaGene Partners with Leading Cancer Research Institutes - Analyst Blog Zacks
11:55AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
08:35AM  Trovagene's Chief Scientific Officer to Present Precision Cancer Monitoring (SM) Platform Overview at the Personalized Medicine World Conference PR Newswire
Jan-21-15 08:21AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online -5.17%
03:01AM  Trovagene Expands Collaboration with Genomac to Demonstrate Clinical Utility in Lung and Colorectal Cancer Treatment Monitoring PR Newswire
Jan-20-15 12:02PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
08:15AM  Clinical Study Results Presented at the 2015 Gastrointestinal Cancer Symposium Support Utility of Trovagene's Precision Cancer Monitoring Platform in Colorectal and Pancreatic Cancer Patients PR Newswire
Jan-12-15 11:26AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
08:35AM  Trovagene Collaborates with UC San Diego Moores Cancer Center to Demonstrate Clinical Utility of Detecting and Monitoring EGFR Mutations in Lung Cancer Patients PR Newswire
Jan-08-15 09:32AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online +8.12%
08:00AM  Trovagene and City of Hope Collaborate To Monitor EGFR Mutational Status in Lung Cancer Patients PR Newswire
Jan-07-15 09:11AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online +6.54%
09:00AM  Trovagene to Present at the 7th Annual Biotech Showcase Conference PR Newswire
Jan-06-15 12:18PM  TROVAGENE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online
06:00AM  Former President of BIO Joins Trovagene's Board of Directors PR Newswire
Dec-04-14 04:07PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online +5.26%
09:05AM  Trovagene Announces Presentation of Clinical Data at the 56th American Society of Hematology Annual Meeting PR Newswire
Nov-26-14 09:05AM  Trovagene to Present at 26th Annual Piper Jaffray Healthcare Conference PR Newswire -5.12%
Nov-21-14 04:35PM  TrovaGene Cancer Technology Detects KRAS Mutation Zacks
Nov-20-14 04:07PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online +8.31%
09:08AM  Trovagene Releases Clinical Study Results for the Detection and Monitoring of KRAS Mutations in Circulating Tumor DNA of Colorectal Cancer Patients PR Newswire
Nov-12-14 08:15AM  Trovagene to Present at Upcoming Healthcare Conferences PR Newswire
Nov-06-14 04:13PM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
04:05PM  Trovagene, Inc. Announces Third Quarter 2014 Financial Results PR Newswire
04:03PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:07AM  Q3 2014 Trovagene Inc Earnings Release - 4:00 pm ET CCBN
Nov-05-14 02:40PM  What's in Store for TrovaGene (TROV) This Earnings Season? Zacks
Oct-29-14 08:10AM  Trovagene Schedules Release of Third Quarter 2014 Financial Results and Investor Conference Call PR Newswire
Oct-27-14 08:10AM  Clinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery PR Newswire
Oct-06-14 04:30PM  Trovagene to Present at 13th Annual BIO Investor Forum PR Newswire
Oct-03-14 06:00AM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online +8.14%
Oct-01-14 08:05AM  Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium PR Newswire -5.90%
Sep-29-14 08:05AM  Trovagene Expands Clinical Program with New Study Evaluating its Precision Cancer Monitoring Platform in Lung Cancer PR Newswire +5.12%
Sep-18-14 04:00PM  TROVAGENE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
Sep-17-14 08:05AM  Cancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board PR Newswire
Sep-15-14 07:50AM  Can The Uptrend Continue for TrovaGene (TROV)? Zacks
Sep-08-14 06:49AM  Increased Earnings Estimates Seen for TrovaGene (TROV): Can It Move Higher? Zacks
Sep-04-14 06:59AM  How TrovaGene (TROV) Stock Stands Out in a Strong Industry Zacks
Aug-26-14 08:24AM  Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics PR Newswire
07:07AM  TrovaGene (TROV) Jumps: Stock Rises 9.2% Zacks
Aug-25-14 08:05AM  Clinical Results Presented for Trovagene's Urine-Based High-Risk HPV Assay. PR Newswire +9.18%
Aug-22-14 07:33AM  Can the Rally in TrovaGene (TROV) Shares Continue? Zacks
Aug-20-14 04:47PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
08:05AM  Trovagene Provides Update on Its Urine-Based HPV Test PR Newswire
Aug-18-14 07:00AM  TrovaGene (TROV) Worth Watching: Stock Rises 8.8% Zacks +23.33%
Aug-12-14 09:53AM  TrovaGene (TROV) Sees Hammer Chart Pattern: Time to Buy? Zacks +5.20%
08:05AM  Leader in Targeted Drug Development, Peter Hirth, Ph.D., Joins Trovagene's Scientific Advisory Board PR Newswire
Aug-08-14 06:01AM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
Aug-07-14 04:05PM  Trovagene, Inc. Announces Second Quarter 2014 Financial Results PR Newswire
04:01PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
07:07AM  Q2 2014 Trovagene Inc Earnings Release - 4:00 pm ET CCBN
Jul-30-14 08:05AM  Trovagene Schedules Release of Second Quarter 2014 Financial Results and Investor Conference Call PR Newswire +5.63%
Jul-10-14 06:09AM  Coverage initiated on TrovaGene by Maxim Group Briefing.com
Jul-01-14 04:27PM  TROVAGENE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obliga EDGAR Online
08:05AM  Trovagene Secures $15 Million in Debt Financing From Silicon Valley Bank and Oxford Finance PR Newswire
Jun-30-14 08:07AM  Trovagene enters into strategic alliance with Lurie Cancer Center, NMDTI theflyonthewall.com
08:05AM  Trovagene Enters Into a Strategic Alliance with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute PR Newswire
Jun-16-14 08:07AM  Trovagene announces clinical collaboratoin with Dana-Farber Cancer Institute at theflyonthewall.com
08:00AM  Trovagene Announces Clinical Collaboration with Dana-Farber Cancer Institute PR Newswire
Jun-02-14 04:43PM  TROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits EDGAR Online +8.73%
12:45PM  Oncogene Mutation Signal in Urinary Cell Free DNA is Highly Correlated with Treatment Response PR Newswire
May-28-14 04:05PM  Trovagene to Present at Jefferies 2014 Global Healthcare Conference PR Newswire
12:24PM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
09:00AM  Trovagene's Precision Cancer Monitoring Technology Referenced in Multi-Disciplinary Clinical Consensus Guidelines PR Newswire
May-21-14 06:44AM  Ophthotech (OPHT) Jumps: Stock Rises 24.5% Zacks
May-20-14 11:05AM  TROVAGENE, INC. Files SEC form 8-K, Other Events EDGAR Online
09:24AM  TrovaGene (TROV) is Oversold: Can It Recover? Zacks
09:00AM  Trovagene Announces Publication of Data from Clinical Validation Program Using Its Precision Cancer Monitoring Platform PR Newswire
May-14-14 05:00PM  Trovagene Announces Data Presentations, Published Abstracts at Annual Meeting of American Society of Clinical Oncology PR Newswire -9.27%
May-13-14 06:01AM  TROVAGENE, INC. Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
May-12-14 08:12PM  TrovaGene's (TROV) CEO Antonius Schuh on Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
04:08PM  Trovagene reports Q1 EPS (17c), consensus (20c) at theflyonthewall.com
04:06PM  TROVAGENE, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. The company intends to enhance the treatment outcomes for cancer patients through its proprietary technology to detect and quantitatively monitor cell-free DNA using urine or blood samples. It is developing PCM BRAF and KRAS mutation detection tests for detecting mutations in metastatic cancer patients; and HPV HR detection test to detect the presence of various HPV genotypes using a urine sample. The company was formerly known as Xenomics, Inc. and changed its name to Trovagene, Inc. in January 2010. Trovagene, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRIDGER MANAGEMENT, LLC10% OwnerFeb 27Buy5.6279,343445,9082,850,587Feb 27 07:21 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 26Buy5.4278,801427,1012,771,244Feb 27 07:21 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 25Buy5.12105,142538,3272,692,443Feb 27 07:21 PM
BRIDGER MANAGEMENT, LLC10% OwnerFeb 06Buy4.50444,4441,999,9982,587,301Feb 10 04:25 PM
ZANIBONI STEVECFOJun 09Buy3.956,32925,0006,329Jun 10 03:59 PM